Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy

M. Opyrchal, C. Allen, P. Msaouel, I. Iankov, E. Galanis

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


RhoA and its downstream effector Rho-associated coiled-coil-forming kinase (ROCK) are known regulators of the formation of actin cytoskeleton in cells. Actin cytoskeleton is involved in paramyxovirus infection; we, therefore, examined the effect of ROCK inhibition on measles virus (MV) cytopathic effect and replication. Treatment with the ROCK inhibitor, Y27632, significantly increased syncytia size in tumor cell lines following MV infection, associated with cytoskeleton disruption as demonstrated by actin staining. Treatment of prostate cancer, breast cancer and glioblastoma tumor cell lines with Y27632 following MV infection resulted in increased cytopathic effect, as assessed by trypan blue exclusion assays. In addition, there was a significant increase in viral proliferation by at least one log or more as tested in one-step viral growth curves. Increased viral replication was also observed in athymic nude mice bearing MDA-MB-231 xenografts following combination treatment with MV and Y27632. In summary, inhibition of the ROCK kinase by Y27632 enhanced the oncolytic effect of MV and viral proliferation; this approach merits further translational investigation.

Original languageEnglish
Pages (from-to)630-637
Number of pages8
JournalCancer gene therapy
Issue number11
StatePublished - Nov 2013


  • GBM
  • ROCK
  • Rho
  • breast cancer
  • measles virus
  • prostate cancer


Dive into the research topics of 'Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy'. Together they form a unique fingerprint.

Cite this